Work

Abstract B026: Combined inhibition of mammalian target of rapamycin (mTOR) and survivin augments radiation therapy in renal cell carcinoma

Year: 2023

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.kidney23-b026

Authors: Krishnendu Pal, Vijay S. Madamsetty, Hari K. Rachamala, Shamit K. Dutta, Enfeng Wang, Debabrata Mukhopadhyay

Institution: Mayo Clinic in Florida

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4385837942

Cites:

Cited by:

Related to: 10